These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 4695960

  • 21. Tumor immunity in vivo: evidence that immune destruction of tumor leaves "bystander" cells intact.
    Weissman IL.
    J Natl Cancer Inst; 1973 Aug; 51(2):443-8. PubMed ID: 4765368
    [No Abstract] [Full Text] [Related]

  • 22. Alloantibody-induced cytotoxicity of macrophages.
    Ptak W, Hanczakowska M.
    J Immunol; 1975 Sep; 115(3):796-9. PubMed ID: 1151077
    [Abstract] [Full Text] [Related]

  • 23. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.
    Gabizon A, Leibovich SJ, Goldman R.
    J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261
    [Abstract] [Full Text] [Related]

  • 24. Kinetic studies of macrophages. VI. The effect of the presence of a solid tumor.
    Gillette RW, Boone CW.
    J Reticuloendothel Soc; 1974 Feb; 15(2):126-31. PubMed ID: 4815212
    [No Abstract] [Full Text] [Related]

  • 25. In vivo studies of the role of cytotoxic T cells in tumor allograft immunity.
    Freedman LR, Cerottini JC, Brunner KT.
    J Immunol; 1972 Dec; 109(6):1371-8. PubMed ID: 4538966
    [No Abstract] [Full Text] [Related]

  • 26. Humoral and cellular immune factors in the systemic control of artifically induced metastases in C3Hf mice.
    Vaage J.
    Cancer Res; 1973 Aug; 33(8):1957-65. PubMed ID: 4720805
    [No Abstract] [Full Text] [Related]

  • 27. Role of macrophages in tumour immunity. II. Involvement of a macrophage cytophilic factor during syngeneic tumour growth inhibition.
    Evans R, Alexander P.
    Immunology; 1972 Oct; 23(4):627-36. PubMed ID: 4563478
    [Abstract] [Full Text] [Related]

  • 28. Immunochemical and biologic characterization of alloantibody active in immunologic enhancement.
    Fuller TC, Winn HJ.
    Transplant Proc; 1973 Mar; 5(1):585-7. PubMed ID: 4695953
    [No Abstract] [Full Text] [Related]

  • 29. Synergistic cooperation between isoantiserum and immune lymphoid cells: in vitro studies with a syngeneic rat lymphoma.
    Ortiz de Landazuri M, Kedar E, Fahey JL.
    J Immunol; 1974 Jun; 112(6):2102-10. PubMed ID: 4825787
    [No Abstract] [Full Text] [Related]

  • 30. Macrophage-mediated, antibody-dependent destruction of tumor cells in DBA/2 mice: in vitro identification of an in situ mechanism.
    Key M, Haskill S.
    J Natl Cancer Inst; 1981 Jan; 66(1):103-10. PubMed ID: 7005500
    [Abstract] [Full Text] [Related]

  • 31. Reticulum cell sarcoma: an effector cell in antibody-dependent cell-mediated immunity.
    Ralph P, Prichard J, Cohn M.
    J Immunol; 1975 Feb; 114(2 pt 2):898-905. PubMed ID: 1089721
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Association of tumor and histocompatibility antigens in sera of lymphoma-bearing mice.
    Fujimoto S, Chen CH, Sabbadini E, Sehon AH.
    J Immunol; 1973 Oct; 111(4):1093-100. PubMed ID: 4728678
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Quantitation of in vivo growth of plasmacytoma X5563 by immunoassay for its paraprotein with individual antigenic specificity.
    Yutoku M, Seno H, Watanabe S, Matsuoka Y, Kitagawa M.
    J Natl Cancer Inst; 1972 Nov; 49(5):1395-402. PubMed ID: 4119497
    [No Abstract] [Full Text] [Related]

  • 36. [In vivo lysis of tumor cells of varying degrees of immune resistance].
    Viksler VKh, Ustinov AS.
    Eksp Onkol; 1989 Nov; 11(3):55-60. PubMed ID: 2752945
    [Abstract] [Full Text] [Related]

  • 37. Macrophage and lymphocyte co-operation in target cell destruction in vitro.
    Zembala M, Ptak W, Hanczakowska M.
    Clin Exp Immunol; 1973 Nov; 15(3):461-6. PubMed ID: 4357983
    [Abstract] [Full Text] [Related]

  • 38. Destruction of murine lymphoma cells by allogeneic peritoneal macrophages in vitro: influence of antiserum.
    Dingemans KP, Pels E, van Dongen G, den Otter W.
    J Natl Cancer Inst; 1983 Jan; 70(1):181-92. PubMed ID: 6571913
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
    Yoshida R, Yoneda Y, Kuriyama M, Kubota T.
    J Immunol; 1999 Jul 01; 163(1):148-54. PubMed ID: 10384111
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.